Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02489461 |
|
Recruitment Status :
Completed
First Posted : July 3, 2015
Last Update Posted : September 25, 2018
|
Sponsor:
Viriom
Information provided by (Responsible Party):
Viriom
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 5, 2016 |
| Actual Study Completion Date : | September 18, 2017 |